Prehospital fibrinolysis was as good as primary angioplasty after myocardial infarction
- Door-to-Balloon Alliance initiative linked to better door-to-balloon times in patients with STEMI undergoing PCI. // Cardiology Today;Feb2010, Vol. 13 Issue 2, p17
The article discusses research on the significant improvement in door-to-door balloon times after the implementation of a Door-to-Balloon initiative in patients hospitalized with ST segment elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention, with a...
- Cardiovascular Research Foundation announces initiation of HORIZONS-AMI II Clinical Trial. // Biomedical Market Newsletter;4/14/2012, Vol. 21, p1
The article informs that the Cardiovascular Research Foundation will be initiating a clinical trial to evaluate Promus Element platinum-chromium stents and Omega bare-metal stents in patients with heart attack undergoing angioplasty.
- Care of the Patient after Coronary Angioplasty. Popma, Jeffrey J.; Dehmer, Gregory J. // Annals of Internal Medicine;4/1/89, Vol. 110 Issue 7, p547
Deals with the care of the patient after coronary angioplasty. Evaluation of the patient after angioplasty; Phases in the management of patients after angioplasty; Angioplasty for acute myocardial infarction.
- The index of microvascular resistance identifies patients with periprocedural myocardial infarction in elective percutaneous coronary intervention. Layland, Jamie J.; Whitbourn, Robert J.; Burns, Andrew T.; Somaratne, Jithendra; Leitl, Georg; MacIsaac, Andrew I.; Wilson, Andrew // Heart;Oct2012, Vol. 98 Issue 20, p1492
Background: This study was designed to assess whether measurement of the index of microvascular resistance (IMR) could help prospectively identify patients who develop periprocedural myocardial infarction (PPMI). Methods and results: IMR was measured in 54 patients before and following...
- Heart drugs can be a bust. Schultz, Stacey // U.S. News & World Report;05/29/2000, Vol. 128 Issue 21, p67
Reports on two studies which show that the clot-busting drugs often given to people who suffer a heart attack can be harmful. Drugs, called thrombolytics, which can benefit younger heart attack victims, but may harm victims over 76-years-old; Angioplasty as a safer option for older heart attack...
- Early detection of the no-reflow phenomenon in reperfused acute myocardial infarction using technetium-99m tetrofosmin imaging. Hamada, Shinichi; Nakamura, Seishi; Sugiura, Tetsuro; Murakami, Takashi; Fujimoto, Toshinori; Watanabe, Junko; Baden, Masato; Hatada, Kengo; Iwasaka, Toshiji // European Journal of Nuclear Medicine;1999, Vol. 26 Issue 3, p208
Abstract. Evaluation of myocardial perfusion in the early stage of acute myocardial infarction (MI) is clinically important for adjunctive therapies to minimize infarct size. To determine the role of early scintigraphic detection of impaired myocardial reperfusion after primary coronary...
- A Better Way to Treat Coronaries. // USA Today Magazine;Feb2000, Vol. 128 Issue 2657, p7
Reports that researchers at Duke University Medical Center in Durham, North Carolina say a heart attack treatment may give coronary patients drugs that dissolve its clots. Methodology of the research; Uses of angioplasty to heart clots and plaques.
- Coronary Stenting plus Platelet Glycoprotein IIb/IIIa Blockade Compared with Tissue Plasminogen Activator in Acute Myocardial Infarction. Schömig, Albert; Kastrati, Adnan; Dirschinger, Josef; Mehilli, Julinda; Schricke, Ullrich; Pache, Jürgen; Martinoff, Stefan; Neumann, Franz-Josef; Schwaiger, Markus // New England Journal of Medicine;08/10/2000, Vol. 343 Issue 6, p385
Background: Prevention of myocardial damage is the main goal of all reperfusion therapies in patients with acute myocardial infarction. The relative efficacy of various reperfusion strategies is under intensive investigation. We assessed whether coronary stenting combined with the blockade of...
- THE PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) GENE LOCUS 4G/5G POLYMORPHISM AND PAI-1 PLASMA LEVELS IN EGYPTIAN PATIENTS WITH MYOCARDIAL INFARCTION. // Egyptian Journal of Biochemistry & Molecular Biology;Jun2011, Vol. 29 Issue 1, p133
No abstract available.